Sufianov, A.,
Bessonova, M.,
Begliarzade, S.,
Kudriashov, V.,
Danilov, A.,
Ilyasova, T.,
Yaolou, W.,
Nafikova, R.,
Beylerli, O. (2023) for proteins, mainly include micro
RNAs,
long non-coding RNAs, and circular
RNAs, play a role in regulating
on
non-coding RNAs and involvement in the same biological processes can become a basis for a complex
), or transcripts over 200 nucleotides in length, defined as
long noncoding RNAs (lnc
RNAs). Lnc
RNAs are a large
transposable elements are key evolutionary sources of
long non-coding RNAs, circular
RNAs, micro
RNAs, proteins
Gareev, Ilgiz,
Encarnacion Ramirez, Manuel de Jesus,
Nurmukhametov, Renat,
Ivliev, Denis,
Shumadalova, Alina,
Ilyasova, Tatiana,
Beilerli, Aferin,
Wang, Chunlei (2023) biomarkers and therapeutic targets specifically tailored for glioma. In recent years,
long non-coding RNAsGareev, I,
Gileva, Y,
Dzidzaria, A,
Beylerli, O,
Pavlov, V,
Agaverdiev, M,
Mazorov, B,
Biganyakov, I,
Vardikyan, A,
Jin, M,
Ahmad, A (2021) ) play a key regulatory role in health and disease.
Long noncoding RNAs (lnc
RNAs) are a group
) and
long non-coding RNAs (lnc
RNAs), as key regulators in the pathogenesis of hypertension. These nc
RNAsBegliarzade, Sema,
Beilerli, Aferin,
Sufianov, Albert,
Tamrazov, Rasim,
Kudriashov, Valentin,
Ilyasova, Tatiana,
Liang, Yanchao,
Beylerli, Ozal (2023) with acetic acid and iodine
solutions. Such highly informative biomarkers can be
long noncoding RNAs (lnc
RNAs an urgent problem of modern medical science and practice.
Long non-coding RNAs (lnc
RNAs)-based therapeutics